Chemical Department
Home > People > Partner > Chemical Department

Fang Tian

Partner,Senior Patent Attorney

Practice Area

Patent invalidation and infringement litigation
Patent layout, application, reply and reexamination
patent analysis and legal opinion services

Qualification

Patent attorney

Education Background

Beijing Normal University, Master degree of Science

Beijing Normal University, Bachelor degree of Science

Working Language

Chinese, English

Membership

All-China Patent Agents Association (ACPAA)

Contact

86-010 6266 9046

tianfang@origintelligence.com

Ms. Fang Tian specializes in protection of intellectual property rights in medicine, pesticide, chemistry and materials. She provides clients with legal services including patent application, reexamination and invalidation, administrative litigation, patent validity analysis, infringement risk analysis, freedom-to-operate and patent layout.

Ms. Tian graduated from Beijing Normal University with a bachelor's degree in chemistry and a master's degree in physical chemistry, respectively. Her intellectual property career began in 2002. She had worked in Beijing Center of Patent Examination Cooperation of China National Intellectual Property Administration(CNIPA) and Patent Reexamination Board of China National Intellectual Property Administration (CNIPA) successively, handled more than 600 invention patent applications, completed more than 50 international search reports and review opinions in English and Chinese in the international phase of PCT applications, completed more than 100 review cases and more than 10 invalid cases as a full-time review officer, and engaged in teaching and research work as a full-time new review officer in the Education Background Department of the Patent Office.

Ms. Tian has provided patent application and reexamination services for domestic universities, research institutions and pharmaceutical enterprises including Peking University, Institute of Chemistry of Chinese Academy of Sciences, Institute of Material Structure of Chinese Academy of Sciences, China Institute of Metrology, SDIC Biotechnology Investment Co., Ltd. and Wuhan Langland Technology Development Co., Ltd., and provided nearly 10 cases of patent validity analysis, infringement risk analysis and FTO analysis services for many pharmaceutical enterprises. Her solid professional knowledge, serious and rigorous attitude and experience in handling difficult cases have been widely recognized by client.

Recent Case

● Representing a pharmaceutical company, successfully declared that the Merck's patent of Etoricoxib crystal form invalid in whole.
● Representing a pharmaceutical company, successfully declared that patent of the crystal form D-Rabeprazole Sodium Monohydrate owned by Jiangsu Chengxin Pharmaceutical invalid in part.
● Representing Yabao Pharmaceutical, successfully declared two patents of Alogliptin preparations held by Takeda Pharmaceutical Industry invalid in whole.
● Representing Qilu Pharmaceutical, successfully declared that the a series of patents of Cinepazide maleate crystal form and the preparation method thereof owned by Sihuan Pharmaceutical invalid in whole.
● Representing the patentee Tianjin Shanjia Pharmaceutical, successfully maintained a series of patents valid and reached a settlement agreement with the defendant in a series of infringement litigations.
● Representing Yanzhou Tiancheng, successfully declared a series of patents of epichlorohydrin process owned by Solvay. Four patents have been declared invalid, and all of them were maintained in the first instance.
© 2020 Origintelligence Intellectual Property Law Firm. All Rights Reserved. 京ICP备19046521号-1         Disclaimer | Privacy statement